← back to search

Tom Lesluyes

Centre de Recherche en Cancérologie de Toulouse · FR
Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Sarcoma Diagnosis and Treatment, Cancer Genomics and Diagnostics, Genomic variations and chromosomal abnormalities, and Microtubule and mitosis dynamics.
h-index
26
citations
2,418
works
120
NIH funding
primary concept
Medicine
email

Recent publications

The History of Chromosomal Instability in Genome-Doubled Tumors
Cancer Discovery 2024cited by 14position: middledoi
Spatiotemporal genomic profiling of intestinal metaplasia reveals clonal dynamics of gastric cancer progression
Cancer Cell 2023cited by 84position: middledoi
Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine
Genome Medicine 2023cited by 12position: middledoi
The history of chromosomal instability in genome doubled tumors
bioRxiv (Cold Spring Harbor Laboratory) 2023cited by 2position: middledoi
Signatures of copy number alterations in human cancer
Nature 2022cited by 505position: middledoi
A pan-cancer compendium of chromosomal instability
Nature 2022cited by 306position: middledoi
<scp>CINSARC</scp> in high‐risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the <scp>ISG‐STS</scp> 1001 study
Cancer Medicine 2022cited by 25position: middledoi
Expression and prognostic significance of PDGF ligands and receptors across soft tissue sarcomas
ESMO Open 2021cited by 27position: middledoi
ATRX Alteration Contributes to Tumor Growth and Immune Escape in Pleomorphic Sarcomas
Cancers 2021cited by 19position: middledoi
Specific immune landscapes and immune checkpoint expressions in histotypes and molecular subtypes of sarcoma
OncoImmunology 2020cited by 47position: middledoi
Clinicopathologic and Molecular Features of a Series of 41 Biphenotypic Sinonasal Sarcomas Expanding Their Molecular Spectrum
The American Journal of Surgical Pathology 2019cited by 89position: middledoi
Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions
Modern Pathology 2018cited by 80position: middledoi
Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors
Modern Pathology 2018cited by 68position: middledoi
Vnn1 pantetheinase limits the Warburg effect and sarcoma growth by rescuing mitochondrial activity
Life Science Alliance 2018cited by 32position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Frédéric Chibon · KU Leuven6 papers (2018–2022)Peter Van Loo · The University of Texas MD Anderson Cancer Center5 papers (2022–2024)Jean‐Yves Blay · International Network for Economic, Social and Cultural Rights5 papers (2018–2022)Maxime Tarabichi · Université Libre de Bruxelles4 papers (2022–2024) · 4 papers (2019–2021)Adrienne M. Flanagan · University College Lahore3 papers (2022–2024)Annelien Verfaillie · KU Leuven3 papers (2022–2024)Antoîne Italiano · Institut Bergonié3 papers (2020–2022)Kerstin Haase · German Cancer Society3 papers (2022–2023)Jean‐Michel Coindre · KU Leuven3 papers (2019–2021)Nischalan Pillay · University of Otago3 papers (2022–2024) · 3 papers (2022–2024)Nicolas Penel · Université de Lille2 papers (2018–2021)Siqi Lai · The University of Texas MD Anderson Cancer Center2 papers (2023–2024)Sylvie Bonvalot · Université Paris Cité2 papers (2020–2021)François Le Loarer · Université Claude Bernard Lyon 12 papers (2019–2021)Gaëlle Pérot · KU Leuven2 papers (2019–2021)Olivier Mir · Amgen (United States)2 papers (2020–2021) · 2 papers (2019–2021) · 2 papers (2019–2021)